Privia Health Group, Inc. logo

Privia Health Group, Inc.

PRVA

NASDAQHealthcareMedical - Healthcare Information Services

Previous close

$21.12

−$0.08 · -0.38%

Aug 21, 4:00 PM ET

PRVA company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Hold

Wait — insufficient conviction to act

Valuation

17

Overpriced

Momentum

61

Gaining

Sentiment

62

Bullish

Risk resilience

76

Moderate Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

Privia Health Group, Inc. functions as a national entity focused on empowering physicians throughout the United States. It partners with medical groups, health plans, and health systems, with the primary objective of optimizing physician practices, enhancing patient experiences, and appropriately compensating clinicians for care delivered both virtually and in person. To achieve this, Privia offers a comprehensive suite of services. These include technology and population health tools designed to streamline independent providers' workflows; a Management Services Organization (MSO) that alleviates administrative tasks, freeing providers to focus on clinical care; a single-TIN medical group, which bolsters payer negotiations, facilitates clinical integration, and aligns financial incentives; an Accountable Care Organization (ACO) designed to engage patients, reduce inefficient utilization, and improve care coordination and patient quality metrics, thereby advancing value-based care; and a network connecting providers with new patient populations and enabling custom contracts with purchasers and payers. Founded in 2007, the company's headquarters are located in Arlington, Virginia. Privia Health Group, Inc. was formerly a subsidiary of Brighton Health Group Holdings, LLC.

Industry
Medical - Healthcare Information Services
Sector
Healthcare
Headquarters
US
CEO
Parth Mehrotra
Listed since
Apr 28, 2021
Employees
1,226

Market position

Day range

Current $21.12

52-week range

Current $21.12

Open
$21.25
Previous close
$21.20
Volume
914.52K
0.81× average
Average volume
1.12M
Average daily volume
Market cap
2.66B USD
Beta
0.9
Market reference 1
50-day average
$24.4968
-13.78% below average
200-day average
$23.3974
-9.73% below average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
2.43B USD
P/E (TTM)
93.91×
P/B (TTM)
P/S (TTM)
1.13×
EV / EBITDA
45.07×
Earnings yield
0.79%
Free cash flow yield
5.60%
Dividend yield
0.00%

Profitability & efficiency

Gross margin
7.61%
Operating margin
1.90%
Net margin
1.19%
Return on equity
3.11%
Return on assets
1.67%
Return on invested capital
2.88%

Financial health

Debt / equity
0.01×
Current ratio
1.6×
Altman Z-score
0.18
Piotroski F-score
2 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends13%0%-13%-26%Gross margin, FY2021: 6.59%Gross margin, FY2022: 9.93%Gross margin, FY2023: 9.74%Gross margin, FY2024: 10.19%Gross margin, FY2025: 9.87%Operating margin, FY2021: -22.50%Operating margin, FY2022: -1.41%Operating margin, FY2023: 1.25%Operating margin, FY2024: 0.98%Operating margin, FY2025: 1.61%Net margin, FY2021: -19.48%Net margin, FY2022: -0.63%Net margin, FY2023: 1.39%Net margin, FY2024: 0.83%Net margin, FY2025: 1.08%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 6.59%. Gross margin FY2022 9.93%. Gross margin FY2023 9.74%. Gross margin FY2024 10.19%. Gross margin FY2025 9.87%. Operating margin FY2021 -22.50%. Operating margin FY2022 -1.41%. Operating margin FY2023 1.25%. Operating margin FY2024 0.98%. Operating margin FY2025 1.61%. Net margin FY2021 -19.48%. Net margin FY2022 -0.63%. Net margin FY2023 1.39%. Net margin FY2024 0.83%. Net margin FY2025 1.08%.

Income trends

Revenue

2.12B USD+22.26%

Operating income

34.24M USD+101.60%

Net income

22.92M USD+59.33%
Income trends across reported periods2.36B USD1.42B USD484.65M USD−451.46M USDRevenue, FY2021: 966.22M USDRevenue, FY2022: 1.36B USDRevenue, FY2023: 1.66B USDRevenue, FY2024: 1.74B USDRevenue, FY2025: 2.12B USDOperating income, FY2021: −217.44M USDOperating income, FY2022: −19.12M USDOperating income, FY2023: 20.65M USDOperating income, FY2024: 16.98M USDOperating income, FY2025: 34.24M USDNet income, FY2021: −188.23M USDNet income, FY2022: −8.59M USDNet income, FY2023: 23.08M USDNet income, FY2024: 14.39M USDNet income, FY2025: 22.92M USDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 966.22M USD. Revenue FY2022 1.36B USD. Revenue FY2023 1.66B USD. Revenue FY2024 1.74B USD. Revenue FY2025 2.12B USD. Operating income FY2021 −217.44M USD. Operating income FY2022 −19.12M USD. Operating income FY2023 20.65M USD. Operating income FY2024 16.98M USD. Operating income FY2025 34.24M USD. Net income FY2021 −188.23M USD. Net income FY2022 −8.59M USD. Net income FY2023 23.08M USD. Net income FY2024 14.39M USD. Net income FY2025 22.92M USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue2.12B USD1.74B USD1.66B USD1.36B USD966.22M USD
Cost of goods sold1.91B USD1.56B USD1.5B USD1.22B USD902.56M USD
Gross profit209.43M USD176.85M USD161.5M USD134.78M USD63.66M USD
Selling, general, and administrative165.29M USD152.6M USD134.32M USD149.33M USD278.63M USD
Operating expenses175.2M USD159.87M USD140.85M USD153.9M USD281.1M USD
Interest income9.7M USD10.89M USD8.37M USD542K USD
Interest expense1.07M USD
Depreciation and amortization9.91M USD7.27M USD6.53M USD4.57M USD2.46M USD
Operating income34.24M USD16.98M USD20.65M USD−19.12M USD−217.44M USD
Net income22.92M USD14.39M USD23.08M USD−8.59M USD−188.23M USD

Company facts updated Aug 24, 2026.

Earnings

EPS beat rate
18%
2 beats, 9 misses, 0 met estimates
Average EPS surprise
-32.32%
11 comparable reports
Latest EPS result
0.07
Estimate 0.07 · Beat by 3.89%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates0.130.090.050.02Q1 '25MissQ2 '25MissQ3 '25MissQ4 '25MissQ1 '26BeatQ2 '26MissQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Feb 27, 2025: actual 0.03, estimate 0.05, surprise -40.00%, Miss. Q2 2025, reported May 8, 2025: actual 0.03, estimate 0.06, surprise -50.00%, Miss. Q3 2025, reported Aug 7, 2025: actual 0.02, estimate 0.05, surprise -60.00%, Miss. Q4 2025, reported Nov 6, 2025: actual 0.05, estimate 0.06, surprise -16.67%, Miss. Q1 2026, reported Feb 26, 2026: actual 0.07, estimate 0.04, surprise +75.00%, Beat. Q2 2026, reported May 7, 2026: actual 0.02, estimate 0.08, surprise -75.00%, Miss. Q3 2026, reported Aug 6, 2026: actual 0.07, estimate 0.067, surprise +3.89%, Beat. Q4 2026, reported Nov 5, 2026: actual —, estimate 0.09, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates657.94M583.05M508.16M433.27MQ1 '25MissQ2 '25BeatQ3 '25BeatQ4 '25BeatQ1 '26BeatQ2 '26BeatQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Feb 27, 2025: actual 460.9M USD, estimate 480.52M USD, surprise -4.08%, Miss. Q2 2025, reported May 8, 2025: actual 480.1M USD, estimate 458.57M USD, surprise +4.69%, Beat. Q3 2025, reported Aug 7, 2025: actual 521.15M USD, estimate 485.56M USD, surprise +7.33%, Beat. Q4 2025, reported Nov 6, 2025: actual 580.42M USD, estimate 516.61M USD, surprise +12.35%, Beat. Q1 2026, reported Feb 26, 2026: actual 541.17M USD, estimate 516.15M USD, surprise +4.85%, Beat. Q2 2026, reported May 7, 2026: actual 603.85M USD, estimate 560.99M USD, surprise +7.64%, Beat. Q3 2026, reported Aug 6, 2026: actual 632.63M USD, estimate 597.33M USD, surprise +5.91%, Beat. Q4 2026, reported Nov 5, 2026: actual —, estimate 610.63M USD, surprise —, Comparison unavailable.

PRVA peers

ETFs holding PRVA

Funds reporting this stock among their holdings, ordered by reported position size.

Continue in GoAI

Research PRVA

research.disclaimer